Last update 29 Nov 2025

CART-38 Cellls(University of Pennsylvania)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
CD38
Action
inhibitors
Mechanism
CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
Relapse multiple myelomaRelapsing acute myeloid leukemia
Originator Organization
University of PennsylvaniaUniversity of Pennsylvania
Active Organization-
Inactive Organization
University of PennsylvaniaUniversity of Pennsylvania
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CART-38 Cellls(University of Pennsylvania)
NCT05442580
/ TerminatedPhase 1IIT
Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB Signaling Domains in Subjects With Acute Myeloid Leukemia and Multiple Myeloma
100 Clinical Results associated with CART-38 Cellls(University of Pennsylvania)
Login to view more data
100 Translational Medicine associated with CART-38 Cellls(University of Pennsylvania)
Login to view more data
100 Patents (Medical) associated with CART-38 Cellls(University of Pennsylvania)
Login to view more data
100 Deals associated with CART-38 Cellls(University of Pennsylvania)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Relapse multiple myelomaPhase 1
United States
University of PennsylvaniaUniversity of Pennsylvania
30 May 2023
Relapsing acute myeloid leukemiaPhase 1
United States
University of PennsylvaniaUniversity of Pennsylvania
30 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free